Ascentage Pharma Trustee Acquires 200,000 Shares for 2022 Restricted Share Unit Plan

Stock News10-22 20:52

Ascentage Pharma (06855) announced that on October 22, 2026, the trustee purchased a total of 200,000 existing shares on the market for the purpose of the 2022 Restricted Share Unit Plan, in order to satisfy restricted share units upon vesting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment